GTC Biotherapeutics (fka GTCB)

[jessellivermore]

Re Timeline DIC.

IMHO It is possible since the P2 trials involve effecacy and twenty eight day mortality rates, that the value of ATynn as a treatment for DIC could be established before the P3 trials begin ie sometime in the first half of 2010 or perhaps sooner.

It is a shame the LEO arrangement did not work out and we are facing this delay. I talked to Rustyboy a couple of days ago and he felt the problem at LEO had something to do with the fact they operate as "charitable organization" or under the aegis of a charitable organization, and this somehow interfered with their ability to donate enough time to ATryn.